We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.89%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+40.89%
3 Year Est. Return
+115.82%
5 Year Est. Return
+132.07%
10 Year Est. Return
+517.81%
AUM
$109B
AUM Growth
+$10.4B
Cap. Flow
+$4.43B
Cap. Flow %
4.04%
Top 10 Hldgs %
18.72%
Holding
8,634
New
1,445
Increased
2,647
Reduced
3,047
Closed
1,267
Avg Time Held Equity + Options
6.9 quarters
Top 10 Avg Time Held Equity + Options
5.6 quarters
Top 20 Avg Time Held Equity + Options
5 quarters
Avg Time Held Equity only
4.8 quarters
Top 10 Avg Time Held Equity only
1.1 quarters
Top 20 Avg Time Held Equity only
1.1 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.22%
2 Technology 7.41%
3 Consumer Discretionary 6.04%
4 Financials 5.89%
5 Industrials 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LKQ icon
4926
CALL
LKQ Corp
LKQ
$5.66B
$480K ﹤0.01%
16,400
-3,200
-16% -$99.5K
2013 Q2
15 quarters
XIFR
4927
CALL
XPLR Infrastructure LP
XIFR
$979M
$480K ﹤0.01%
+14,500
New +$440K
2017 Q1
0 quarters
HEWG
4928
DELISTED
iShares Currency Hedged MSCI Germany ETF
HEWG
$479K ﹤0.01%
17,195
+2,157
+14% +$57.7K
2016 Q2
3 quarters
OTIC
4929
DELISTED
Otonomy, Inc.
OTIC
$479K ﹤0.01%
39,161
+4,757
+14% +$69.3K
2015 Q2
7 quarters
CBM
4930
PUT
DELISTED
Cambrex Corporation
CBM
$479K ﹤0.01%
8,700
+4,200
+93% +$224K
2016 Q4
1 quarter
AQMS icon
4931
Aqua Metals
AQMS
$7.5M
$478K ﹤0.01%
+122
New +$380K
2017 Q1
0 quarters
DAR icon
4932
CALL
Darling Ingredients
DAR
$9.65B
$478K ﹤0.01%
+32,900
New +$433K
2017 Q1
0 quarters
SPHY icon
4933
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$11.8B
$478K ﹤0.01%
18,258
-2,379
-12% -$62.2K
2016 Q2
3 quarters
TREE icon
4934
LendingTree
TREE
$347M
$478K ﹤0.01%
3,813
-52,254
-93% -$5.96M
2016 Q3
2 quarters
GLOP
4935
PUT
DELISTED
GASLOG PARTNERS LP
GLOP
$478K ﹤0.01%
19,500
+4,300
+28% +$98.8K
2016 Q4
1 quarter
SIOX
4936
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$478K ﹤0.01%
4,000
+2,100
+111% +$220K
2016 Q4
1 quarter
PTR
4937
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$478K ﹤0.01%
+6,522
New +$503K
2017 Q1
0 quarters
NUAN
4938
PUT
DELISTED
Nuance Communications, Inc.
NUAN
$478K ﹤0.01%
31,878
-73,227
-70% -$1.04M
2013 Q2
15 quarters
XL
4939
PUT
DELISTED
XL Group Ltd.
XL
$478K ﹤0.01%
12,000
-11,000
-48% -$431K
2013 Q2
15 quarters
GLDD
4940
DELISTED
Great Lakes Dredge & Dock
GLDD
$477K ﹤0.01%
119,238
-19,266
-14% -$88.5K
2016 Q3
2 quarters
XSLV icon
4941
Invesco S&P SmallCap Low Volatility ETF
XSLV
$236M
$477K ﹤0.01%
11,132
-52,899
-83% -$2.26M
2016 Q4
1 quarter
ARRY
4942
CALL
DELISTED
Array Biopharma Inc
ARRY
$477K ﹤0.01%
53,400
-57,100
-52% -$608K
2013 Q4
13 quarters
ERY icon
4943
Direxion Daily Energy Bear 2X ETF
ERY
$51M
$476K ﹤0.01%
837
+356
+74% +$190K
2016 Q2
3 quarters
GFI icon
4944
Gold Fields
GFI
$32.2B
$476K ﹤0.01%
134,914
-143,334
-52% -$484K
2013 Q2
15 quarters
IGE icon
4945
iShares North American Natural Resources ETF
IGE
$787M
$476K ﹤0.01%
13,880
-66,671
-83% -$2.35M
2016 Q4
1 quarter
YINN icon
4946
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$567M
$476K ﹤0.01%
+1,190
New +$453K
2017 Q1
0 quarters
ZYNE
4947
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$476K ﹤0.01%
23,700
+12,500
+112% +$248K
2016 Q4
1 quarter
CMP icon
4948
CALL
Compass Minerals
CMP
$953M
$475K ﹤0.01%
7,000
-5,900
-46% -$450K
2013 Q2
15 quarters
CMPR icon
4949
Cimpress
CMPR
$1.79B
$475K ﹤0.01%
+5,512
New +$477K
2017 Q1
0 quarters
CPT icon
4950
CALL
Camden Property Trust
CPT
$11.3B
$475K ﹤0.01%
5,900
-600
-9% -$49.4K
2013 Q2
15 quarters

Similar funds

Citadel Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.

  • Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
  • Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
  • Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
  • Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
  • Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
  • Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.

Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.